Jo Nash

Minority shareholders biggest litigation threat(2)

Almost half of all private equity firms in a new survey expect litigation to increase in the next two years. But the major threat is unlikely to come from regulators, as most firms seem to think.

Esprit Capital Partners leads €15m Kiadis funding round(3)

Kiadis Pharma, the biotech company backed by European venture capital firm Esprit Capital Partners, has raised €15 million in its latest funding round.

Linklaters poaches Freshfields partner(2)

Leading law firm Linklaters has hired Brian Gray from rival law firm Freshfields Bruckhaus Deringer, as it looks to strengthen its offering to private equity clients.

Krokus raises €100m for Polish fund(2)

Warsaw-based Krokus Private Equity has closed its fourth fund on €100 million – exceeding its target of €75 million – as Poland becomes a more attractive destination for private equity capital.

AVP agrees bolt-on for software business

Pertinence, a French intelligence software business backed by venture capital firms Advent Venture Partners and Partech International, has bought US rival Intercim.

London VCs invest $8m in Daylife(2)

New York-based news aggregation site Daylife has raised $8 million from two UK venture capital firms, in the latest example of US start-ups taking funding from VCs based in London rather than Silicon Valley.

Krokus raises €100m for Polish fund

Warsaw-based Krokus Private Equity has closed its fourth fund on €100 million – exceeding its target of €75 million – as Poland becomes a more attractive destination for private equity capital.

Graphite makes 4.2x return on Go Plant exit(2)

UK mid-market firm Graphite Capital has sold Go Plant, a vehicle hire business, to Easternrange. The sale has generated a return of 4.2 times Graphite’s original investment.

Carlyle floats Transics on Euronext(3)

Global buyout firm The Carlyle Group has floated Transics, a European IT business, on Euronext Brussels. The flotation, which raised €46 million, is the first major exit for the firm’s €222m Europe Technology Partners fund.

Advent bolsters life sciences team(3)

London-based Advent Venture Partners has expanded its life sciences team with the recruitment of two new partners – both former biotech entrepreneurs.